|
Dules in a subpleural, perihilar, and bronchovascular distribution. Fissures are thickened. Paratracheal (arrow), bilateral hilar (arrow) and subcarinal (arrow) lymph nodes are also demonstrated. Differential Diagnosis Infections (tuberculous, fungal) Sarcoidosis Metastasis Pneumoconiosis Hypersensitivity lung disease Diagnosis Sarcoidosis (stage II) Discussion In sarcoidosis, clinical staging is based on the chest radiograph: Stage 0: Normal chest radiograph Stage I: Hilar and mediastinal lymph node enlargement Stage II: Lymphadenopathy and parenchymal disease Stage III: Parenchymal disease only Stage IV: Pulmonary fibrosis Intrathoracic lymphadenopathy is the most common finding in sarcoidosis occurring in over 85% of patients. The most common pattern is right paratracheal and bilateral hilar adenopathy (the "1,2,3 sign"). Unusual patterns of lymph node enlargement occasionally occur. While not common, paratracheal, subcarinal, aortopulmonary window, and other mediastinal lymph node
pulmonary sarcoidosis S CHORUS Collaborative Hypertext of Radiology Respiratory system About CHORUS Disclaimer Copyright Search Feedback pulmonary sarcoidosis Classification Ihilar mediastinal lymph nodes (43%) IInodes + lung dz (41%) IIIlung dz only (16%) mid and upper lobe predominance frequently associated with TB rare superinfection w Aspergillus HRCT: hilar adenopathy early = septal thickening pulmonary sarcoidosis, peribronchovascular nodules pulmonary sarcoidosis, alveolitis pulmonary sarcoidosis, ground-glass opacity late = traction bronchiectasis pulmonary sarcoidosis, fibrosis pulmonary sarcoidosis, honeycombing See: sarcoidosis Charles E. Kahn pulmonary sarcoidosis, Jr. pulmonary sarcoidosis, MD - 10 March 1995 Last updated 26 May 2004 Related CHORUS documents: sarcoidosis honeycomb lung honeycombing eosinophilic granuloma Kveim test rheumatoid lung disease Search for related articles: AJR: American Journal of Roentgenology PubMed: index to biomedical literature MedPix: teaching file Copyright © 2004 pulmonary sarcoidosis, Charles E. Kahn pulmonary sarcoidosis, Jr. Medical College of Wisconsin pulmonary sarcoidosis.
pulmonary sarcoidosis N unpredictable course. Oral (OCS) or inhaled steroids (ICS) are widely used in its treatment pulmonary sarcoidosis, but there is no consensus about when and in whom therapy should be initiated pulmonary sarcoidosis, what dose should be given and for how long. Corticosteroids given for several months have deleterious side-effects so it is important to know whether they have any maintained benefit in pulmonary sarcoidosis.Objectives: To determine the randomised controlled trial (RCT) evidence for the benefit of corticosteroids (oral or inhaled) in the treatment of pulmonary sarcoidosis.Search strategy: MEDLINE pulmonary sarcoidosis, EMBASE and CENTRAL were searched using predefined terms. Bibliographies of retrieved RCTs and reviews were searched for additional RCTs. Pharmaceutical companies and authors of identified RCTs were contacted for other published and unpublished studies. Searches are current as of May 2004.Selection criteria: Two reviewers independently assessed full text articles for inclusion based upon the following criteria: the study ha.
pulmonary sarcoidosis Ult human being pulmonary sarcoidosis, without patronizing me and without scorn for what I may or may not know about my condition. I have one doctor who acts as coordinator of my care pulmonary sarcoidosis, keeping track of all my medications and receiving notes from all of the other doctors I see to collect all of this information in one place. I see specialists to deal with specific issues and problems pulmonary sarcoidosis, with any information from them returned to that coordinator. A Note About Health Insurance Like most working Americans pulmonary sarcoidosis, I am covered by private health insurance. As a person with a chronic disease pulmonary sarcoidosis, I've learned that I need to make sure that my medical coverage continues if and when I change jobs pulmonary sarcoidosis, so that insurers are not given the opportunity to not cover me. This may sounds like I am trying to trick the insurers pulmonary sarcoidosis, but I do not see it that way. There are many ways for them to see that I do not abuse the system even though I may submit the most claims of anyone in my group health plan. I am entitled to that coverage under the law.
pulmonary sarcoidosis 
pulmonary sarcoidosis | | | | | | pulmonary sarcoidosis
L calculi or nephrocalcinosis with consequent renal failure, but prednisone has reduced the frequency of disordered Ca metabolism. Hyperparathyroidism appears to be unusually frequent and should be considered when hypercalcemia does not promptly respond to corticosteroids. Laboratory Findings and Diagnosis Chest x-ray abnormalities occur in 90% of patients. Mediastinal adenopathy often is discovered on routine chest x-ray. X-ray findings of bilateral hilar and right paratracheal adenopathy are virtually universal (90% of patients), although adenopathy occasionally is unilateral. Pulmonary infiltration may have a diffuse, fine, ground-glass appearance on x-ray. It may accompany or follow adenopathy; occur without visible adenopathy; occur as reticular or miliary lesions; or be present as confluent infiltrations or large nodules resembling metastases. Cough and dyspnea may be minimal or absent. Pulmonary fibrosis, cystic changes, and cor pulmonale are late results of progressive disease.
|